Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)

Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)

Abstract Background We launched a single‐arm phase II study to determine the efficacy and cost‐effectiveness of percutaneous endoscopic gastrostomy (PEG) before concurrent chemoradiotherapy (CCRT) in patients with esophageal squamous cell carcinoma (ESCC). Methods Eligible patients received pretreat...

Full description

Bibliographic Details
Main Authors: XinLei Ai, PengXin Zhang, XinMin Xie, Bo Qiu, YuJia Zhu, Lei Zhao, Mian Xi, YingJia Wu, SuPing Guo, JinYu Guo, FangJie Liu, DaQuan Wang, NaiBin Chen, QianWen He, YongHong Hu, MengZhong Liu, ZhaoXia Ding, Hui Liu
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Cancer Medicine
Subjects:
concurrent chemoradiotherapy
cost‐effectiveness analysis
esophageal squamous cell carcinoma
percutaneous endoscopic gastrostomy
Online Access:https://doi.org/10.1002/cam4.6136

Internet

https://doi.org/10.1002/cam4.6136

Similar Items